Chapter 6: Lung cancer in never smokers: Epidemiology and risk prediction models

Risk Analysis

Volumn 32, Issue SUPPL.1, 2012, Pages

  Mccarthy, William J ^a,b,c   Meza, Rafael ^d   Jeon, Jihyoun ^e   Moolgavkar, Suresh H ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Lung cancer; Never smokers; Risk prediction models

Indexed keywords

ENVIRONMENTAL TOBACCO SMOKES; GENETIC SUSCEPTIBILITY; LUNG CANCER; LUNG CANCER MORTALITY; NEVER SMOKERS; OCCUPATIONAL EXPOSURE; RADON GAS; RISK FACTORS; RISK PREDICTIONS; SECONDHAND SMOKES; SURVEILLANCE NETWORKS;

BIOLOGICAL ORGANS; IONIZING RADIATION; MATHEMATICAL MODELS; ONCOGENIC VIRUSES; RISK ASSESSMENT;

DISEASES;

RADON;

CANCER; DISEASE INCIDENCE; DISEASE PREVALENCE; EPIDEMIOLOGY; LITERATURE REVIEW; MORTALITY; OCCUPATIONAL EXPOSURE; PREDATION RISK; RISK FACTOR; SMOKE; SMOKING; VIRUS;

ADULT; AGE; AGED; ARTICLE; FEMALE; GAS; GENETIC PREDISPOSITION; HUMAN; IONIZING RADIATION; LUNG TUMOR; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RISK; SEX DIFFERENCE; SMOKING; STATISTICAL MODEL; THEORETICAL MODEL;

ADULT; AGE FACTORS; AGED, 80 AND OVER; FEMALE; GASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MODELS, THEORETICAL; OCCUPATIONAL EXPOSURE; RADIATION, IONIZING; RADON; RISK; SEX FACTORS; SMOKING;

NICOTIANA TABACUM;

EID: 84864926209     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2012.01768.x     Document Type: Article

References (119)

1. Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and productivity losses: United States, 1997-2001. Morbidity and Mortality Weekly Report, 2005; 54(25):625-628.
2. Thun MJ, Hannan LM, Adams-Campbell LL, Boffetta P, Buring JE, Feskanich D, Flanders WD, Jee SH, Katanoda K, Kolonel LN, Lee IM, Marugame T, Palmer JR, Riboli E, Sobue T, Avila-Tang E, Wilkens LR, Samet JM. Lung cancer occurrence in never-smokers: An analysis of 13 cohorts and 22 cancer registry studies. PLoS Medicine, 2008; 5(9):e185.
3. Schultz FW, Boer R, de Koning HJ. Description of MISCAN-Lung, the Erasmus MC lung cancer microsimulation model for evaluating cancer control interventions. Risk Analysis, 2012; 32(S1):S85-S98
4. Hazelton WD, Jeon J, Meza R, Moolgavkar SH. The FHCRC lung cancer model. Risk Analysis, 2012; 32(S1):S99-S116.
5. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS. The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Analysis, 2012; 32(S1):S117-S124.
6. Levy DT, Blackman K, Zaloshnja E. A macro-model of smoking and lung cancer: Examining aggregate trends in lung cancer rates unsing the CPS-I and CPS-II and two-stage clonal expansion models. Risk Analysis, 2012; 32(S1):S125-S141.
7. Foy M, Deng L, Spitz M, Gorlova O, Kimmel M. Rice-MD Anderson lung cancer model. Risk Analysis, 2012; 32(S1):S142-S150.
8. Holford TR, Ebisu K, McKay L, Oh C, Zheng T. Yale lung cancer model. Risk Analysis, 2012; 32(S1):S151-S165.
9. McMahon PM, Hazelton WD, Kimmel M, Clarke LD. CISNET lung models: Comparison of model assumptions and model structures. Risk Analysis, 2012; 32(S1):S166-S178.
10. World Health Organization. Guidelines for Controlling and Monitoring the Tobacco Epidemic. Geneva: World Health Organization, 1998.
11. Subramanian J, Govindan R. Lung cancer in never smokers: A review. Journal of Clinical Oncology, 2007; 25(5):561-570.
12. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers: A different disease. Nature Reviews Cancer, 2007; 7(10):778-790.
13. Samet JM, Avila-Tang E, Boffetta P, Hannan LM, Olivo-Marston S, Thun MJ, Rudin CM. Lung cancer in never smokers: Clinical epidemiology and environmental risk factors. Clinical and Cancer Research, 2009; 15(18):5626-5645.
14. Pierce DA, Mendelsohn ML. A model for radiation-related cancer suggested by atomic bomb survivor data. Radiation Research, 1999; 152(6):642-654.
15. Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. British Journal of Radiology, 2008; 81(965):362-378.
16. Doll R. The age distribution of cancer: Implications for models of carcinogenesis. Journal of the Royal Statistical Society. Series A (General) 1971; 134(2):133-166.
17. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: Dose and time relationships among regular smokers and lifelong non-smokers. Journal of Epidemiology and Community Health, 1978; 32(4):303-313.
18. Meza R, Hazelton WD, Colditz GA, Moolgavkar SH. Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals' Follow-Up Studies using a multistage carcinogenesis model. Cancer Causes Control, 2008; 19(3):317-328.
19. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. Journal of the National Cancer Institute, 2006; 98(10):691-699.
20. USDHHS. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Available at: http://www.surgeongeneral.gov/library/secondhandsmoke/report/fullreport.pdf, Accessed on February 25, 2010.
21. Taylor R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: Effects of study type and continent. International Journal of Epidemiology, 2007; 36(5):1048-1059.
22. Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environmental Health Perspectives, 2006; 114(6):853-858.
23. Jefferis BJ, Thomson AG, Lennon LT, Feyerabend C, Doig M, McMeekin L, Wannamethee SG, Cook DG, Whincup PH. Changes in environmental tobacco smoke (ETS) exposure over a 20-year period: Cross-sectional and longitudinal analyses. Addiction 2009; 104(3):496-503.
24. Veglia F, Vineis P, Overvad K, Boeing H, Bergmann M, Trichopoulou A, Trichopoulos D, Palli D, Krogh V, Tumino R, Linseisen J, Steindorf K, Raaschou-Nielsen O, Tjonneland A, Gonzalez CA, Martinez C, Dorronsoro M, Barricarte A, Cirera L, Quiros JR, Day NE, Saracci R, Riboli E. Occupational exposures, environmental tobacco smoke, and lung cancer. Epidemiology 2007; 18(6):769-775.
25. Yu IT, Chiu YL, Au JS, Wong TW, Tang JL. Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. Cancer Research, 2006; 66(9):4961-4967.
26. Wang XR, Chiu YL, Qiu H, Au JS, Yu IT. The roles of smoking and cooking emissions in lung cancer risk among Chinese women in Hong Kong. Annals of Oncology, 2009; 20(4):746-751.
27. Chiu YL, Wang XR, Qiu H, Yu IT. Risk factors for lung cancer: A case-control study in Hong Kong women. Cancer Causes and Control, 2010; 21(5):777-785.
28. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of household solid fuel combustion and of high-temperature frying. Lancet Oncology, 2006; 7(12):977-978.
29. Young SC, Chang LW, Lee HL, Tsai LH, Liu YC, Lin P. DNA damages induced by trans, trans-2, 4-decadienal (tt-DDE), a component of cooking oil fume, in human bronchial epithelial cells. Environmental and Molecular Mutagenesis, 2010; 51(4):315-321.
30. Dung CH, Wu SC, Yen GC. Genotoxicity and oxidative stress of the mutagenic compounds formed in fumes of heated soybean oil, sunflower oil and lard. Toxicology in Vitro, 2006; 20(4):439-447.
31. Chang LW, Lo WS, Lin P. Trans, trans-2, 4-decadienal, a product found in cooking oil fumes, induces cell proliferation and cytokine production due to reactive oxygen species in human bronchial epithelial cells. Journal of Toxicological Sciences, 2005; 87(2):337-343.
32. Mettler FA, Jr., Bhargavan M, Faulkner K, Gilley DB, Gray JE, Ibbott GS, Lipoti JA, Mahesh M, McCrohan JL, Stabin MG, Thomadsen BR, Yoshizumi TT. Radiologic and nuclear medicine studies in the United States and worldwide: Frequency, radiation dose, and comparison with other radiation sources-1950-2007. Radiology, 2009; 253(2):520-531.
33. Brenner DJ, Hall EJ. Computed tomography: An increasing source of radiation exposure. New England Journal of Medicine, 2007; 357(22):2277-2284.
34. Lubin JH, Boice JD, Jr., Edling C, Hornung RW, Howe GR, Kunz E, Kusiak RA, Morrison HI, Radford EP, Samet JM. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. Journal of the National Cancer Institute, 1995; 87(11):817-827.
35. Qiao YL, Taylor PR, Yao SX, Schatzkin A, Mao BL, Lubin J, Rao JY, McAdams M, Xuan XZ, Li JY. Relation of radon exposure and tobacco use to lung cancer among tin miners in Yunnan Province, China. American Journal of Industrial Medicine, 1989; 16(5):511-521.
36. Radford EP, Renard KG. Lung cancer in Swedish iron miners exposed to low doses of radon daughters. New England Journal of Medicine, 1984; 310(23):1485-1494.
37. Roscoe RJ, Steenland K, Halperin WE, Beaumont JJ, Waxweiler RJ. Lung cancer mortality among nonsmoking uranium miners exposed to radon daughters. Journal of the American Medical Association, 1989; 262(5):629-633.
38. Tirmarche M, Raphalen A, Allin F, Chameaud J, Bredon P. Mortality of a cohort of French uranium miners exposed to relatively low radon concentrations. British Journal of Cancer, 1993; 67(5):1090-1097.
39. Tomasek L, Darby SC, Swerdlow AJ, Placek V, Kunz E. Radon exposure and cancers other than lung cancer among uranium miners in West Bohemia. Lancet 1993; 341(8850):919-923.
40. Xuan XZ, Lubin JH, Li JY, Yang LF, Luo AS, Lan Y, Wang JZ, Blot WJ. A cohort study in southern China of tin miners exposed to radon and radon decay products. Health Physics, 1993; 64(2):120-131.
41. Hazelton WD, Luebeck EG, Heidenreich WF, Moolgavkar SH. Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette smoke, and pipe smoke exposures using the biologically based two-stage clonal expansion model. Radiation Research, 2001; 156(1):78-94.
42. Darby S, Hill D, Auvinen A, Barros-Dios JM, Baysson H, Bochicchio F, Deo H, Falk R, Forastiere F, Hakama M, Heid I, Kreienbrock L, Kreuzer M, Lagarde F, Makelainen I, Muirhead C, Oberaigner W, Pershagen G, Ruano-Ravina A, Ruosteenoja E, Rosario AS, Tirmarche M, Tomasek L, Whitley E, Wichmann HE, Doll R. Radon in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European case-control studies. British Medical Journal, 2005; 330(7485):223-228.
43. Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Letourneau EG, Lynch CF, Lyon JL, Sandler DP, Schoenberg JB, Steck DJ, Stolwijk JA, Weinberg C, Wilcox HB. A combined analysis of North American case-control studies of residential radon and lung cancer. Journal of Toxicology and Environmental. Health A, 2006; 69(7):533-597.
44. Fisher EL, Field RW, Smith BJ, Lynch CF, Steck DJ, Neuberger JS. Spatial variation of residential radon concentrations: The Iowa Radon Lung Cancer Study. Health Physics, 1998; 75(5):506-513.
45. Berman DW, Crump KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Critical Reviews in Toxicology, 2008; 38(Suppl. 1):49-73.
46. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Annals of Occupational Hygiene, 2000; 44(8):565-601.
47. Moolgavkar SH, Luebeck EG, Krewski D, Zielinski JM. Radon, cigarette smoke, and lung cancer: A re-analysis of the Colorado Plateau uranium miners' data. Epidemiology, 1993; 4(3):204-217.
48. Goodman M, Morgan RW, Ray R, Malloy CD, Zhao K. Cancer in asbestos-exposed occupational cohorts: A meta-analysis. Cancer Causes and Control, 1999; 10(5):453-465.
49. McDonald JC, Harris J, Armstrong B. Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby, Montana. Journal of Occupational and Environmental Medicine, 2004; 61(4):363-366.
50. Loomis D, Dement JM, Wolf SH, Richardson DB. Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers. Journal of Occupational and Environmental Medicine, 2009; 66(8):535-542.
51. Moolgavkar SH, Turim J, Alexander DD, Lau EC, Cushing CA. Potency factors for risk assessment at Libby, Montana. Risk Analysis, 2010; 30(8):1240-1248.
52. Wraith D, Mengersen K. Assessing the combined effect of asbestos exposure and smoking on lung cancer: A Bayesian approach. Statistics in Medicine, 2007; 26(5):1150-1169.
53. Liddell FD, Armstrong BG. The combination of effects on lung cancer of cigarette smoking and exposure in Quebec chrysotile miners and millers. Annals of Occupational Hygiene, 2002; 46(1):5-13.
54. Liddell FD. The interaction of asbestos and smoking in lung cancer. Annals of Occupational Hygiene, 2001; 45(5):341-356.
55. Truong T, Hung RJ, Amos CI, Wu X, Bickeboller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, Wrensch M, Hansen H, Kelsey KT, Matsuo K, Tajima K, Schwartz AG, Wenzlaff A, Seow A, Ying C, Staratschek-Jox A, Nurnberg P, Stoelben E, Wolf J, Lazarus P, Muscat JE, Gallagher CJ, Zienolddiny S, Haugen A, van der Heijden HF, Kiemeney LA, Isla D, Mayordomo JI, Rafnar T, Stefansson K, Zhang ZF, Chang SC, Kim JH, Hong YC, Duell EJ, Andrew AS, Lejbkowicz F, Rennert G, Muller H, Brenner H, Le Marchand L, Benhamou S, Bouchardy C, Teare MD, Xue X, McLaughlin J, Liu G, McKay JD, Brennan P, Spitz MR. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 21: A pooled analysis from the International Lung Cancer Consortium. Journal of the National Cancer Institute, 2010; 102(13):959-971.
56. Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD, Chang IS, Chatterjee N, Brennan P, Wu C, Zheng W, Chang GC, Wu T, Park JY, Hsiao CF, Kim YH, Shen H, Seow A, Yeager M, Tsai YH, Kim YT, Chow WH, Guo H, Wang WC, Sung SW, Hu Z, Chen KY, Kim JH, Chen Y, Huang L, Lee KM, Lo YL, Gao YT, Kim JH, Liu L, Huang MS, Jung TH, Jin G, Caporaso N, Yu D, Kim CH, Su WC, Shu XO, Xu P, Kim IS, Chen YM, Ma H, Shen M, Cha SI, Tan W, Chang CH, Sung JS, Zhang M, Yang TY, Park KH, Yuenger J, Wang CL, Ryu JS, Xiang Y, Deng Q, Hutchinson A, Kim JS, Cai Q, Landi MT, Yu CJ, Park JY, Tucker M, Hung JY, Lin CC, Perng RP, Boffetta P, Chen CY, Chen KC, Yang SY, Hu CY, Chang CK, Fraumeni JF, Jr., Chanock S, Yang PC, Rothman N, Lin D. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genetics, 2010; 6(8):e1001051.
57. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Wang Y, Krokan H, Vatten L, Skorpen F, Arnesen E, Benhamou S, Bouchard C, Metspalu A, Vooder T, Nelis M, Valk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeboller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF, Jr., Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. American Journal of Human Genetics, 2009; 85(5):679-691.
58. Jin G, Xu L, Shu Y, Tian T, Liang J, Xu Y, Wang F, Chen J, Dai J, Hu Z, Shen H. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis, 2009; 30(6):987-990.
59. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, McLaughlin J, Shepherd F, Montpetit A, Narod S, Krokan HE, Skorpen F, Elvestad MB, Vatten L, Njolstad I, Axelsson T, Chen C, Goodman G, Barnett M, Loomis MM, Lubinski J, Matyjasik J, Lener M, Oszutowska D, Field J, Liloglou T, Xinarianos G, Cassidy A, EPIC Study, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, Gonzalez CA, Ramon Quiros J, Martinez C, Navarro C, Ardanaz E, Larranaga N, Kham KT, Key T, Bueno-de-Mesquita HB, Peeters PH, Trichopoulou A, Linseisen J, Boeing H, Hallmans G, Overvad K, Tjonneland A, Kumle M, Riboli E, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P. Lung cancer susceptibility locus at 5p15.33. Nature Genetics, 2008; 40(12):1404-1406.
60. Wang XR, Yu IT, Chiu YL, Qiu H, Fu Z, Goggins W, Au JS, Tse LA, Wong TW. Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes and Control, 2009; 20(5):757-763.
61. Gao Y, Goldstein AM, Consonni D, Pesatori AC, Wacholder S, Tucker MA, Caporaso NE, Goldin L, Landi MT. Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. International Journal of Cancer, 2009; 125(1):146-152.
62. Schwartz AG, Ruckdeschel JC. Familial lung cancer: Genetic susceptibility and relationship to chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 2006; 173(1):16-22.
63. Amos CI, Pinney SM, Li Y, Kupert E, Lee J, de Andrade MA, Yang P, Schwartz AG, Fain PR, Gazdar A, Minna J, Wiest JS, Zeng D, Rothschild H, Mandal D, You M, Coons T, Gaba C, Bailey-Wilson JE, Anderson MW. A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. Cancer Research, 2010; 70(6): 2359-2367.
64. Arheart KL, Lee DJ, Dietz NA, Wilkinson JD, Clark JD, 3rd, LeBlanc WG, Serdar B, Fleming LE. Declining trends in serum cotinine levels in US worker groups: The power of policy. Journal of Occupational and Environmental Medicine, 2008; 50(1):57-63.
65. Widome R, Jacobs DR, Jr., Schreiner PJ, Iribarren C. Passive smoke exposure trends and workplace policy in the Coronary Artery Risk Development in Young Adults (CARDIA) study (1985-2001). Preventive Medicine, 2007; 44(6):490-495.
66. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 1999; 160(5 Pt 1):1668-1672.
67. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Current Opinion in Pulmonary Medicine, 2005; 11(5):431-437.
68. Hollins DM, McKinley MA, Williams C, Wiman A, Fillos D, Chapman PS, Madl AK. Beryllium and lung cancer: A weight of evidence evaluation of the toxicological and epidemiological literature. Critical Reviews in Toxicology, 2009; 39(Suppl. 1):1-32.
69. Sanderson WT, Ward EM, Steenland K, Petersen MR. Lung cancer case-control study of beryllium workers. American Journal of Industrial Medicine, 2001; 39(2):133-44.
70. Steenland K, Sanderson W. Lung cancer among industrial sand workers exposed to crystalline silica. American Journal of Epidemiology, 2001; 153(7):695-703.
71. Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: A systematic review and meta-analysis. PLoS One, 2011; 6(3):e17479.
72. Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunological Reviews, 2000; 173:39-51.
73. Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR, Chanock SJ, Goedert JJ, Engels EA. C-reactive protein and risk of lung cancer. Journal of Clinical Oncology, 2010; 28(16):2719-2726.
74. Fitzpatrick FA. Inflammation, carcinogenesis and cancer. International Immunopharmacology, 2001; 1(9-10):1651-1667.
75. Coussens LM, Werb Z. Inflammation and cancer. Nature, 2002; 420(6917):860-867.
76. Kundu JK, Surh YJ. Inflammation: Gearing the journey to cancer. Mutation Research, 2008; 659(1-2):15-30.
77. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: Findings from the Renfrew and Paisley prospective population study. British Medical Journal, 1996; 313(7059):711-715.
78. Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, Zhou BS. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: A systematic review. International Journal of Cancer, 2009; 125(12):2936-2944.
79. Santillan AA, Camargo CA, Jr., Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes and Control, 2003; 14(4):327-334.
80. Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, Ruckdeschel JC, Gadgeel S, Soubani AO. Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. Journal of Thoracic Oncology, 2009; 4(3):291-299.
81. Purdue MP, Gold L, Jarvholm B, Alavanja MC, Ward MH, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax, 2007; 62(1):51-56.
82. Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G. The role of human papilloma virus in lung cancer: A review of the evidence. American Journal of the Medical Sciences, 2009; 338(1):64-67.
83. Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer, 2009; 65(1):13-18.
84. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer Journal for Clinicians, 2011; 61(4):212-236.
85. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. British Medical Journal, 1976; 2(6051):1525-1536.
86. Blot WJ, Fraumeni JF, Jr. Cancers of the lung and pleura. In Schottenfeld D, Fraumeni JF, Jr. (eds). Cancer Epidemiology and Prevention. New York: Oxford University Press, 1996.
87. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest, 2004; 126(2):347-351.
88. Rudin CM, Avila-Tang E, Harris CC, Herman JG, Hirsch FR, Pao W, Schwartz AG, Vahakangas KH, Samet JM. Lung cancer in never smokers: Molecular profiles and therapeutic implications. Clinical Cancer Research, 2009; 15(18): 5646-5661.
89. Fujisawa T, Iizasa T, Saitoh Y, Sekine Y, Motohashi S, Yasukawa T, Shibuya K, Hiroshima K, Ohwada H. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. Journal of Clinical Oncology, 1999; 17(7):2086-2091.
90. Yoshino I, Kawano D, Oba T, Yamazaki K, Kometani T, Maehara Y. Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Annals of Thoracic Surgery, 2006; 81(4):1189-1193.
91. Thatcher N, Chang A, Parikh P, Rodrigues Pereira J, Ciuleanu T, von Pawel J, Thongprasert S, Tan EH, Pemberton K, Archer V, Carroll K. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet, 2005; 366(9496):1527-1537.
92. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S, Smylie M, Martins R, van Kooten M, Dediu M, Findlay B, Tu D, Johnston D, Bezjak A, Clark G, Santabarbara P, Seymour L, National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. New England Journal of Medicine, 2005; 353(2):123-132.
93. Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer, 2006; 106(11):2428-2436.
94. Subramanian J, Velcheti V, Gao F, Govindan R. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology, 2007; 2(9):827-830.
95. Meguid RA, Hooker CM, Harris J, Xu L, Westra WH, Sherwood JT, Sussman M, Cattaneo SM, 2nd, Shin J, Cox S, Christensen J, Prints Y, Yuan N, Zhang J, Yang SC, Brock MV. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: Comparing never smokers and current smokers. Chest, 2010; 138(3):500-509.
96. Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. Journal of Clinical Oncology, 2004; 22(6): 1103-1109.
97. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW. Lung cancer incidence in never smokers. Journal of Clinical Oncology, 2007; 25(5):472-478.
98. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC. Cigarette smoking and subsequent risk of lung cancer in men and women: Analysis of a prospective cohort study. Lancet Oncology, 2008; 9(7):649-656.
99. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. Journal of Clinical Oncology, 2006; 24(28):4539-4544.
100. Wisnivesky JP, Halm EA. Sex differences in lung cancer survival: Do tumors behave differently in elderly women? Journal of Clinical Oncology, 2007; 25(13):1705-1712.
101. Schwartz AG, Swanson GM. Lung carcinoma in African Americans and whites. A population-based study in metropolitan Detroit, Michigan. Cancer, 1997; 79(1):45-52.
102. Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S, JPHC Study Group. Japanese Public Health Center. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: The JPHC study. International Journal of Cancer, 2002; 99(2):245-251.
103. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature, 2009; 458(7239):719-724.
104. Feuer EJ, Levy DT, McCarthy WJ. The impact of the reduction in tobacco smoking on US lung cancer mortality, 1975-2000: An introduction to the problem (Ch. 1 of this monograph). Risk Analysis.
105. Moolgavkar SH, Venzon DJ. Two-event models for carcinogenesis: Incidence curves for childhood and adult tumors. Mathematical Biosciences, 1979; 47(1):55-77.
106. Moolgavkar SH, Knudson AG, Jr. Mutation and cancer: A model for human carcinogenesis. Journal of the National Cancer Institute, 1981; 66(6):1037-1052.
107. Hazelton WD, Clements MS, Moolgavkar SH. Multistage carcinogenesis and lung cancer mortality in three cohorts. Cancer Epidemiology, Biomarkers & Prevention, 2005; 14(5):1171-1181.
108. National Center for Health and Statistic. U.S. Decennial Life Tables for 1989-91, Vol 1. Hyattsville, MD: U.S. Department of Health and Human Services, 1997.
109. Knoke JD, Burns DM, Thun MJ. The change in excess risk of lung cancer attributable to smoking following smoking cessation: An examination of different analytic approaches using CPS-I data. Cancer Causes and Control, 2008; 19(2):207-219.
110. Anderson CM, Burns DM, Dodd KW, Feuer EJ. Birth cohort specific estimates of smoking behaviors for the U.S. population. Risk Analysis, 2012; 32(S1):S14-S24.
111. Holford TR, Clarke LD. Development of the counterfactual smoking histories used to assess the effects of tobacco control. Risk Analysis, 2012; 32(S1):S39-S50
112. Jeon J, Meza R, Krapcho M, Clarke LD, Byrne J, Levy DT. Actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation. Risk Analysis, 2012; 32(S1):S51-S68
113. Bernert JT, Pirkle JL, Xia Y, Jain RB, Ashley DL, Sampson EJ. Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure. Cancer Epidemiology, Biomarkers & Prevention, 2010; 19(11):2969-2977.
114. Ellis JA, Gwynn C, Garg RK, Philburn R, Aldous KM, Perl SB, Thorpe L, Frieden TR. Secondhand smoke exposure among nonsmokers nationally and in New York City. Nicotine & Tobacco Research, 2009; 11(4):362-370.
115. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke: The Third National Health and Nutrition Examination Survey, 1988 to 1991. Journal of the American Medical Association, 1996; 275(16):1233-1240.
116. Church TR, Anderson KE, Le C, Zhang Y, Kampa DM, Benoit AR, Yoder AR, Carmella SG, Hecht SS. Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers. Biomarkers, 2010; 15(4):345-352.
117. Bernert JT, Gordon SM, Jain RB, Brinkman MC, Sosnoff CS, Seyler TH, Xia Y, McGuffey JE, Ashley DL, Pirkle JL, Sampson EJ. Increases in tobacco exposure biomarkers measured in non-smokers exposed to sidestream cigarette smoke under controlled conditions. Biomarkers, 2009; 14(2):82-93.
118. Hsieh SJ, Ware LB, Eisner MD, Yu L, Jacob P, 3rd, Havel C, Goniewicz ML, Matthay MA, Benowitz NL, Calfee CS. Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. Critical Care Medicine, 2011; 39(1):40-45.
119. Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, Sobczak A, Havel C, Jacob P, Benowitz NL. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine & Tobacco Research, 2011; 13(3):202-208.